$1.54 Billion is the total value of SABBY MANAGEMENT, LLC's 194 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ISHARES MSCI JAPAN ETFput | $59,550,000 | – | 50,000 | +100.0% | 3.87% | – | |
| New | ISHARES 20+ YEAR TREASURY BOND ETFcall | $45,220,000 | – | 4,250 | +100.0% | 2.94% | – | |
| New | ISHARES RUSSELL 2000 ETFput | $37,082,000 | – | 3,478 | +100.0% | 2.41% | – | |
| New | GLAXOSMITHKLINE PLCcall | $32,766,000 | – | 6,531 | +100.0% | 2.13% | – | |
| New | BIOGEN IDEC INCcall | $21,042,000 | – | 874 | +100.0% | 1.37% | – | |
| New | OPKO HEALTH INCcall | $16,767,000 | – | 19,032 | +100.0% | 1.09% | – | |
| New | CELLDEX THERAPEUTICS INCcall | $16,234,000 | – | 4,582 | +100.0% | 1.06% | – | |
| ALXN | New | ALEXION PHARMACEUTICALS INCcall | $12,963,000 | – | 1,116 | +100.0% | 0.84% | – |
| New | ASTRAZENECA PLC-SPONS ADRput | $10,698,000 | – | 2,060 | +100.0% | 0.70% | – | |
| ANTH | New | ANTHERA PHARMACEUTICALS INC | $7,053,000 | – | 1,754,600 | +100.0% | 0.46% | – |
| New | PHARMACYCLICS INCcall | $6,229,000 | – | 450 | +100.0% | 0.40% | – | |
| New | GLAXOSMITHKLINE PLCput | $5,920,000 | – | 1,180 | +100.0% | 0.38% | – | |
| New | SYNAGEVA BIOPHARMA CORPcall | $5,825,000 | – | 920 | +100.0% | 0.38% | – | |
| New | BLACKBERRY LTDput | $5,005,000 | – | 6,296 | +100.0% | 0.32% | – | |
| AGEN | New | AGENUS INC | $4,885,000 | – | 1,763,663 | +100.0% | 0.32% | – |
| New | CELLDEX THERAPEUTICS INCput | $4,032,000 | – | 1,138 | +100.0% | 0.26% | – | |
| New | ISIS PHARMACEUTICALS INCput | $3,762,000 | – | 1,002 | +100.0% | 0.24% | – | |
| New | BIOMARIN PHARMACEUTICAL INCcall | $3,012,000 | – | 417 | +100.0% | 0.20% | – | |
| NVAX | New | NOVAVAX INC | $2,765,000 | – | 875,000 | +100.0% | 0.18% | – |
| New | EXELIXIS INCcall | $2,425,000 | – | 4,167 | +100.0% | 0.16% | – | |
| New | HOLOGIC INCcall | $2,292,000 | – | 1,110 | +100.0% | 0.15% | – | |
| New | ACADIA PHARMACEUTICALS INCput | $2,288,000 | – | 833 | +100.0% | 0.15% | – | |
| New | INSMED INCput | $2,248,000 | – | 1,440 | +100.0% | 0.15% | – | |
| New | PHARMACYCLICS INCput | $2,146,000 | – | 155 | +100.0% | 0.14% | – | |
| SZYM | New | SOLAZYME INC | $2,136,000 | – | 198,350 | +100.0% | 0.14% | – |
| New | SOLAZYME INCput | $2,115,000 | – | 1,964 | +100.0% | 0.14% | – | |
| XOMA | New | XOMA CORP | $2,041,000 | – | 455,672 | +100.0% | 0.13% | – |
| New | MEDICINES COcall | $2,028,000 | – | 605 | +100.0% | 0.13% | – | |
| New | VANDA PHARMACEUTICALS INCcall | $2,004,000 | – | 1,827 | +100.0% | 0.13% | – | |
| PCYC | New | PHARMACYCLICS INC | $1,709,000 | – | 12,350 | +100.0% | 0.11% | – |
| New | VANDA PHARMACEUTICALS INCput | $1,662,000 | – | 1,515 | +100.0% | 0.11% | – | |
| OVAS | New | OVASCIENCE INC | $1,605,000 | – | 162,000 | +100.0% | 0.10% | – |
| ACRX | New | ACELRX PHARMACEUTICALS INC | $1,595,000 | – | 148,070 | +100.0% | 0.10% | – |
| ACHN | New | ACHILLION PHARMACEUTICALS INC | $1,464,000 | – | 484,879 | +100.0% | 0.10% | – |
| ASTM | New | AASTROM BIOSCIENCES INC | $1,437,000 | – | 5,189,214 | +100.0% | 0.09% | – |
| TGTX | New | TG THERAPEUTICS INC | $1,402,000 | – | 275,479 | +100.0% | 0.09% | – |
| AZN | New | ASTRAZENECA PLC-SPONS ADRadr | $1,381,000 | – | 26,585 | +100.0% | 0.09% | – |
| ONTY | New | ONCOTHYREON INC | $1,359,000 | – | 659,600 | +100.0% | 0.09% | – |
| New | UNITED THERAPEUTICS CORPcall | $1,325,000 | – | 168 | +100.0% | 0.09% | – | |
| New | EXACT SCIENCES CORPcall | $1,211,000 | – | 1,025 | +100.0% | 0.08% | – | |
| New | UNI-PIXEL INCcall | $1,200,000 | – | 677 | +100.0% | 0.08% | – | |
| CLDX | New | CELLDEX THERAPEUTICS INC | $1,133,000 | – | 31,979 | +100.0% | 0.07% | – |
| FCSC | New | FIBROCELL SCIENCE INC | $1,099,000 | – | 251,000 | +100.0% | 0.07% | – |
| New | AVANIR PHARMACEUTICALS INCput | $1,074,000 | – | 2,534 | +100.0% | 0.07% | – | |
| ISR | New | ISORAY INC | $1,079,000 | – | 1,663,098 | +100.0% | 0.07% | – |
| New | ACCURAY INCput | $1,035,000 | – | 1,400 | +100.0% | 0.07% | – | |
| TMP | New | TONIX PHARMACEUTICALS HOLDING | $1,024,000 | – | 288,454 | +100.0% | 0.07% | – |
| RNN | New | REXAHN PHARMACEUTICALS INC | $1,013,000 | – | 2,250,840 | +100.0% | 0.07% | – |
| SCON | New | SUPERCONDUCTOR TECHNOLOGIES | $1,004,000 | – | 619,600 | +100.0% | 0.06% | – |
| New | NEKTAR THERAPEUTICSput | $941,000 | – | 900 | +100.0% | 0.06% | – | |
| CNAT | New | CONATUS PHARMACEUTICALS INC | $921,000 | – | 91,600 | +100.0% | 0.06% | – |
| New | IMMUNOCELLULAR THERAPEUTICS LTDput | $914,000 | – | 3,557 | +100.0% | 0.06% | – | |
| ASTX | New | ASTEX PHARMACEUTICALS INC | $845,000 | – | 99,703 | +100.0% | 0.06% | – |
| New | SYNTA PHARMACEUTICALS CORPcall | $791,000 | – | 1,253 | +100.0% | 0.05% | – | |
| New | XOMA CORPput | $742,000 | – | 1,656 | +100.0% | 0.05% | – | |
| VICL | New | VICAL INC | $727,000 | – | 581,595 | +100.0% | 0.05% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $710,000 | – | 198,259 | +100.0% | 0.05% | – |
| New | ZIOPHARM ONCOLOGY INCput | $712,000 | – | 1,803 | +100.0% | 0.05% | – | |
| NSPH | New | NANOSPHERE INC | $690,000 | – | 345,121 | +100.0% | 0.04% | – |
| New | NEKTAR THERAPEUTICScall | $686,000 | – | 656 | +100.0% | 0.04% | – | |
| New | GERON CORPput | $697,000 | – | 2,080 | +100.0% | 0.04% | – | |
| DYAX | New | DYAX CORP | $682,000 | – | 99,458 | +100.0% | 0.04% | – |
| ARIA | New | ARIAD PHARMACEUTICALS INC | $581,000 | – | 31,553 | +100.0% | 0.04% | – |
| New | ENDOCYTE INCput | $547,000 | – | 410 | +100.0% | 0.04% | – | |
| ONXX | New | ONYX PHARMACEUTICALS INC | $504,000 | – | 4,045 | +100.0% | 0.03% | – |
| SLXP | New | SALIX PHARMACEUTICALS LTD | $473,000 | – | 7,073 | +100.0% | 0.03% | – |
| KBIO | New | KALOBIOS PHARMACEUTICALS INC | $476,000 | – | 105,408 | +100.0% | 0.03% | – |
| New | MEI PHARMAcall | $454,000 | – | 400 | +100.0% | 0.03% | – | |
| New | BIOCRYST PHARMACEUTICALS INCcall | $446,000 | – | 613 | +100.0% | 0.03% | – | |
| ISIS | New | ISIS PHARMACEUTICALS INC | $438,000 | – | 11,663 | +100.0% | 0.03% | – |
| New | CUBIST PHARMACEUTICALS INCput | $394,000 | – | 62 | +100.0% | 0.03% | – | |
| GERN | New | GERON CORP | $366,000 | – | 109,375 | +100.0% | 0.02% | – |
| New | NUPATHE INCput | $369,000 | – | 1,531 | +100.0% | 0.02% | – | |
| ACOR | New | ACORDA THERAPEUTICS INCcall | $369,000 | – | 108 | +100.0% | 0.02% | – |
| New | GERON CORPcall | $376,000 | – | 1,122 | +100.0% | 0.02% | – | |
| New | PLURISTEM THERAPEUTICS INCput | $351,000 | – | 1,038 | +100.0% | 0.02% | – | |
| NBIX | New | NEUROMETRIX INC | $361,000 | – | 218,849 | +100.0% | 0.02% | – |
| EWJ | New | ISHARES MSCI JAPAN ETFetf | $298,000 | – | 25,000 | +100.0% | 0.02% | – |
| New | BRISTOL MYERS SQUIBB COput | $278,000 | – | 60 | +100.0% | 0.02% | – | |
| DNDNQ | New | DENDREON CORP | $263,000 | – | 89,800 | +100.0% | 0.02% | – |
| New | ARROWHEAD RESEARCH CORPcall | $250,000 | – | 439 | +100.0% | 0.02% | – | |
| New | ONCOTHYREON INCcall | $230,000 | – | 1,116 | +100.0% | 0.02% | – | |
| New | ACELRX PHARMACEUTICALS INCcall | $215,000 | – | 200 | +100.0% | 0.01% | – | |
| New | ACCURAY INCcall | $188,000 | – | 254 | +100.0% | 0.01% | – | |
| New | ENDOCYTE INCcall | $143,000 | – | 107 | +100.0% | 0.01% | – | |
| New | APRICUS BIOSCIENCES INCput | $109,000 | – | 264 | +100.0% | 0.01% | – | |
| New | CHEMOCENTRYX INCput | $86,000 | – | 155 | +100.0% | 0.01% | – | |
| New | AGENUS INCcall | $96,000 | – | 347 | +100.0% | 0.01% | – | |
| New | SEQUENOM INCcall | $78,000 | – | 293 | +100.0% | 0.01% | – | |
| OXBT | New | OXYGEN BIOTHERAPEUTICS INC | $54,000 | – | 36,715 | +100.0% | 0.00% | – |
| New | SEQUENOM INCput | $55,000 | – | 205 | +100.0% | 0.00% | – | |
| New | ATHERSYS INCput | $40,000 | – | 245 | +100.0% | 0.00% | – | |
| New | CYTRX CORPcall | $40,000 | – | 125 | +100.0% | 0.00% | – | |
| SQNM | New | SEQUENOM INC | $41,000 | – | 15,400 | +100.0% | 0.00% | – |
| New | ONCOLYTICS BIOTECH INCcall | $24,000 | – | 100 | +100.0% | 0.00% | – | |
| New | ATHERSYS INCcall | $22,000 | – | 133 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2013-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 40 | Q2 2024 | 49.1% |
| ISHARES TR | 38 | Q2 2024 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| ISHARES TR | 20 | Q2 2024 | 12.7% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyngn Inc. | January 04, 2024 | 5,322,048 | 10.0% |
| iBio, Inc. | January 04, 2024 | 200,303 | 10.0% |
| InMed Pharmaceuticals Inc. | January 04, 2024 | 524,972 | 10.0% |
| Phunware, Inc. | January 04, 2024 | 10,006,584 | 5.9% |
| TREASURE GLOBAL INC | January 04, 2024 | 5,338,587 | 10.0% |
| Arcadia Biosciences, Inc. | January 03, 2024 | 97,305 | 8.8% |
| Bluejay Diagnostics, Inc. | January 03, 2024 | 177,513 | 10.0% |
| Fangdd Network Group Ltd. | January 03, 2024 | 600,427 | 10.0% |
| GlucoTrack, Inc. | January 03, 2024 | 2,087,130 | 10.0% |
| LIPELLA PHARMACEUTICALS INC. | January 03, 2024 | 579,814 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-04 |
| 4 | 2024-09-03 |
| 4 | 2024-08-30 |
| 4 | 2024-08-28 |
| 4 | 2024-08-26 |
| 4 | 2024-08-22 |
| 4 | 2024-08-20 |
| 4 | 2024-08-16 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-08-14 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.